Iterative design of selective Type II JAK2 Inhibitor for superior management of myelofibrosis
Fields of Study & Subjects
Myeloproliferative Neoplasms: Diagnosis and Treatment
Computational Drug Discovery Methods
Synthesis and biological activity
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 17 February 2026
- Language
- EN